Conduit Pharmaceuticals Statistics
Total Valuation
CDT has a market cap or net worth of $5.93 million. The enterprise value is $12.83 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CDT has 6.66 million shares outstanding. The number of shares has increased by 27.71% in one year.
| Current Share Class | 6.66M |
| Shares Outstanding | 6.66M |
| Shares Change (YoY) | +27.71% |
| Shares Change (QoQ) | +28.40% |
| Owned by Insiders (%) | 0.89% |
| Owned by Institutions (%) | 1.58% |
| Float | 3.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -0.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.25
| Current Ratio | 0.25 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.24 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -168.82% |
| Return on Invested Capital (ROIC) | -1,616.93% |
| Return on Capital Employed (ROCE) | 235.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.54M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.75% in the last 52 weeks. The beta is 2.27, so CDT's price volatility has been higher than the market average.
| Beta (5Y) | 2.27 |
| 52-Week Price Change | -99.75% |
| 50-Day Moving Average | 2.02 |
| 200-Day Moving Average | 21.43 |
| Relative Strength Index (RSI) | 35.99 |
| Average Volume (20 Days) | 1,353,035 |
Short Selling Information
The latest short interest is 751,366, so 11.28% of the outstanding shares have been sold short.
| Short Interest | 751,366 |
| Short Previous Month | 451,046 |
| Short % of Shares Out | 11.28% |
| Short % of Float | 23.59% |
| Short Ratio (days to cover) | 0.51 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.42M |
| Pretax Income | n/a |
| Net Income | -17.80M |
| EBITDA | -14.96M |
| EBIT | -15.42M |
| Earnings Per Share (EPS) | -$20.53 |
Full Income StatementBalance Sheet
The company has $554,000 in cash and $7.46 million in debt, giving a net cash position of -$6.90 million or -$1.04 per share.
| Cash & Cash Equivalents | 554,000 |
| Total Debt | 7.46M |
| Net Cash | -6.90M |
| Net Cash Per Share | -$1.04 |
| Equity (Book Value) | -6.79M |
| Book Value Per Share | -4.91 |
| Working Capital | -8.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.68 million and capital expenditures -$51,000, giving a free cash flow of -$9.73 million.
| Operating Cash Flow | -9.68M |
| Capital Expenditures | -51,000 |
| Free Cash Flow | -9.73M |
| FCF Per Share | -$1.46 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |